These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 3490611)
1. Interactions of the 1-methyl-4-phenyl-2,3-dihydropyridinium species with synthetic dopamine-melanin. Wu EY; Chiba K; Trevor AJ; Castagnoli N Life Sci; 1986 Nov; 39(18):1695-700. PubMed ID: 3490611 [TBL] [Abstract][Full Text] [Related]
2. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin. D'Amato RJ; Lipman ZP; Snyder SH Science; 1986 Feb; 231(4741):987-9. PubMed ID: 3080808 [TBL] [Abstract][Full Text] [Related]
3. Oxygen activation during the interaction between MPTP metabolites and synthetic neuromelanin--an ESR-spin trapping, optical, and oxidase electrode study. Korytowski W; Felix CC; Kalyanaraman B Biochem Biophys Res Commun; 1988 Jul; 154(2):781-8. PubMed ID: 2840906 [TBL] [Abstract][Full Text] [Related]
4. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases. Singer TP; Salach JI; Castagnoli N; Trevor A Biochem J; 1986 May; 235(3):785-9. PubMed ID: 3489461 [TBL] [Abstract][Full Text] [Related]
5. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae. Trevor AJ; Castagnoli N; Caldera P; Ramsay RR; Singer TP Life Sci; 1987 Feb; 40(8):713-9. PubMed ID: 3492651 [TBL] [Abstract][Full Text] [Related]
6. Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Peterson LA; Caldera PS; Trevor A; Chiba K; Castagnoli N J Med Chem; 1985 Oct; 28(10):1432-6. PubMed ID: 3876442 [TBL] [Abstract][Full Text] [Related]
7. Neuromelanin: a role in MPTP-induced neurotoxicity. D'Amato RJ; Alexander GM; Schwartzman RJ; Kitt CA; Price DL; Snyder SH Life Sci; 1987 Feb; 40(8):705-12. PubMed ID: 2880274 [TBL] [Abstract][Full Text] [Related]
8. Role of 1-methyl-4-phenylpyridinium ion formation and accumulation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity to isolated hepatocytes. Di Monte D; Ekström G; Shinka T; Smith MT; Trevor AJ; Castagnoli N Chem Biol Interact; 1987; 62(2):105-16. PubMed ID: 3496169 [TBL] [Abstract][Full Text] [Related]
9. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Castagnoli N; Chiba K; Trevor AJ Life Sci; 1985 Jan; 36(3):225-30. PubMed ID: 3871243 [TBL] [Abstract][Full Text] [Related]
10. Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP+ by Transporter-Independent Export of the Intermediate MPDP+. Schildknecht S; Pape R; Meiser J; Karreman C; Strittmatter T; Odermatt M; Cirri E; Friemel A; Ringwald M; Pasquarelli N; Ferger B; Brunner T; Marx A; Möller HM; Hiller K; Leist M Antioxid Redox Signal; 2015 Nov; 23(13):1001-16. PubMed ID: 26413876 [TBL] [Abstract][Full Text] [Related]
11. 1-Methyl-4-phenyl-2,3-dihydropyridinium is transformed by ubiquinone to the selective nigrostriatal toxin 1-methyl-4-phenylpyridinium. Shi H; Noguchi N; Xu Y; Niki E FEBS Lett; 1999 Nov; 461(3):196-200. PubMed ID: 10567696 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelanin. D'Amato RJ; Benham DF; Snyder SH J Neurochem; 1987 Feb; 48(2):653-8. PubMed ID: 3491879 [TBL] [Abstract][Full Text] [Related]
13. Metabolic studies on the nigrostriatal toxin MPTP and its MAO B generated dihydropyridinium metabolite MPDP+. Wu E; Shinka T; Caldera-Munoz P; Yoshizumi H; Trevor A; Castagnoli N Chem Res Toxicol; 1988; 1(3):186-94. PubMed ID: 2979730 [TBL] [Abstract][Full Text] [Related]
14. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685 [TBL] [Abstract][Full Text] [Related]
15. Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Chiba K; Peterson LA; Castagnoli KP; Trevor AJ; Castagnoli N Drug Metab Dispos; 1985; 13(3):342-7. PubMed ID: 2861994 [TBL] [Abstract][Full Text] [Related]
16. Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria. Ramsay RR; Singer TP J Biol Chem; 1986 Jun; 261(17):7585-7. PubMed ID: 3486869 [TBL] [Abstract][Full Text] [Related]
17. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes. Chiba K; Trevor AJ; Castagnoli N Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939 [TBL] [Abstract][Full Text] [Related]
18. Mutagenicity of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and its metabolites. Cashman JR Toxicology; 1987 Feb; 43(2):173-82. PubMed ID: 2949395 [TBL] [Abstract][Full Text] [Related]
19. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat. Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293 [TBL] [Abstract][Full Text] [Related]
20. Processing of MPTP by monoamine oxidases: implications for molecular toxicology. Trevor AJ; Singer TP; Ramsay RR; Castagnoli N J Neural Transm Suppl; 1987; 23():73-89. PubMed ID: 3295117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]